Assignee
BAXTER AG
AT·70 granted patents·3 pending applications·2,340 citations·filing 1992–2008
Top patents by PatentIndex Score
73 records- 0199US6936441B2Recombinant cell clones having increased stability and methods of making and using the sameBAXTER AG·Filed 2002·Granted Aug 30, 2005·160 cites·27 claims
- 0297US7094574B2Recombinant cell clones having increased stability and methods of making and using the sameBAXTER AG·Filed 2005·Granted Aug 22, 2006·32 cites·10 claims
- 0397US6620125B1Method and device for mixing and applying components of differing viscositiesBAXTER AG·Filed 2000·Granted Sep 16, 2003·104 cites·14 claims
- 0497US6224862B1Pharmaceutical preparation for treating blood coagulation disordersBAXTER AG·Filed 2000·Granted May 1, 2001·88 cites·4 claims
- 0596US6475725B1Recombinant cell clones having increased stability and methods of making and using the sameBAXTER AG·Filed 1999·Granted Nov 5, 2002·119 cites·34 claims
- 0695US7033590B1Factor IX/factor IXa activating antibodies and antibody derivativesBAXTER AG·Filed 2000·Granted Apr 25, 2006·47 cites·22 claims
- 0793US6316226B1Proteins with Factor VIII activity: process for their preparation using genetically-engineered cells and pharmaceutical compositions containing themBAXTER AG·Filed 1995·Granted Nov 13, 2001·143 cites·8 claims
- 0892US6372223B1Influenza virus vaccine compositionBAXTER AG·Filed 1999·Granted Apr 16, 2002·101 cites·8 claims
- 0991US6926894B2Composition exhibiting a von willebrand factor (vWF) protease activity comprising a polypeptide chain with the amino acid sequence AAGGILHLELLVBAXTER AG·Filed 2001·Granted Aug 9, 2005·39 cites·27 claims
- 1091US6146873AProduction of orthomyxoviruses in monkey kidney cells using protein-free mediaBAXTER AG·Filed 1997·Granted Nov 14, 2000·158 cites·37 claims
- 1190US7279161B2Factor IX/factor IXa activating antibodies and antibody derivativesBAXTER AG·Filed 2005·Granted Oct 9, 2007·6 cites·9 claims
- 1290US6228613B1Stable factor VIII/von Willebrand factor complexBAXTER AG·Filed 1997·Granted May 8, 2001·53 cites·40 claims
- 1389US7220569B2Nucleic acids encoding factor X analogues having a modified protease cleavage siteBAXTER AG·Filed 2003·Granted May 22, 2007·37 cites·16 claims
- 1489US6013620APharmaceutical composition for the treatment of blood coagulation diseases, methods for the production thereof and its useBAXTER AG·Filed 1997·Granted Jan 11, 2000·79 cites·25 claims
- 1588US7241603B2Method for producing a preparation based on fibrinogen and fibronectin as well as protein compositions obtainable according to this methodBAXTER AG·Filed 2002·Granted Jul 10, 2007·25 cites·8 claims
- 1688US6596526B1Furin polypeptides with improved characteristicsBAXTER AG·Filed 2000·Granted Jul 22, 2003·20 cites·15 claims
- 1788US6017891AStable preparation for the treatment of blood coagulation disordersBAXTER AG·Filed 1997·Granted Jan 25, 2000·78 cites·27 claims
- 1886US6114146AExpression plasmid, a fusion protein, a transfected eukaryotic cell line, a method of producing foreign proteins, a foreign protein preparation as well as a pharmaceutical compositionBAXTER AG·Filed 1995·Granted Sep 5, 2000·94 cites·31 claims
- 1985US7892802B2Fibrinogen-based tissue adhesive containing an elastase inhibitorBAXTER AG·Filed 2008·Granted Feb 22, 2011·7 cites·23 claims
- 2085US6958322B1Factor X analog with an improved ability to be activatedBAXTER AG·Filed 2000·Granted Oct 25, 2005·18 cites·29 claims
- 2185US6579537B2Method for producing fibronectin and fibrinogen compositions using a polyalkylene glycol and glycine or β-alanineBAXTER AG·Filed 2000·Granted Jun 17, 2003·27 cites·18 claims
- 2283US7459295B2Fibrinogen-based tissue adhesive containing an elastase inhibitorBAXTER AG·Filed 2006·Granted Dec 2, 2008·7 cites·12 claims
- 2383US6210929B1Fusion protein comprising a furin derivative or a derivative of a furin analogue and a heterologous sequenceBAXTER AG·Filed 1996·Granted Apr 3, 2001·43 cites·22 claims
- 2482US6905846B2Nucleic acids encoding factor X deletion mutants and analogues thereofBAXTER AG·Filed 2003·Granted Jun 14, 2005·15 cites·17 claims
- 2581US6953837B2Factor VIII/vWF complexes and compositionsBAXTER AG·Filed 2001·Granted Oct 11, 2005·12 cites·6 claims
- 2681US6670116B2Methods for the detection, quantification and differentiation of infectious versus non-infectious pathogens in a sampleBAXTER AG·Filed 2000·Granted Dec 30, 2003·10 cites·25 claims
- 2781US6506365B1Fibrin/fibrinogen binding conjugateBAXTER AG·Filed 2000·Granted Jan 14, 2003·14 cites·22 claims
- 2881US6136321AMethod of inactivating lipid-enveloped virusesBAXTER AG·Filed 1998·Granted Oct 24, 2000·50 cites·16 claims
- 2980US6649162B1Hemostatic sponge based on collagenBAXTER AG·Filed 1997·Granted Nov 18, 2003·86 cites·2 claims
- 3079US6974792B2Alpha 1-antitrypsin preparation as well as a method for producing the sameBAXTER AG·Filed 2001·Granted Dec 13, 2005·24 cites·15 claims
- 3178US6924151B2Stable factor VIII/vWF-complexBAXTER AG·Filed 2001·Granted Aug 2, 2005·3 cites·13 claims
- 3278US6713453B2Fibrin/fibrinogen-binding conjugateBAXTER AG·Filed 2001·Granted Mar 30, 2004·9 cites·45 claims
- 3378US6103244AMethods for generating immune responses employing modified vaccinia of fowlpox virusesBAXTER AG·Filed 1996·Granted Aug 15, 2000·36 cites·14 claims
- 3477US6086871AProthrombin derivativesBAXTER AG·Filed 1996·Granted Jul 11, 2000·39 cites·22 claims
- 3576US6777390B1Stable blood coagulation inhibitor-free factor vii preparation and method for preparing sameBAXTER AG·Filed 1999·Granted Aug 17, 2004·29 cites·27 claims
- 3674US6103693AMethod for isolation of highly pure von willebrand factorBAXTER AG·Filed 1997·Granted Aug 15, 2000·27 cites·13 claims
- 3773US6573071B1Factor X analogues with a modified protease cleavage siteBAXTER AG·Filed 1998·Granted Jun 3, 2003·29 cites·64 claims
- 3873US6358918B1Preparation comprising thiol-group-containing proteinsBAXTER AG·Filed 2000·Granted Mar 19, 2002·7 cites·33 claims
- 3972US6562598B1Factor X deletion mutants and analogues thereofBAXTER AG·Filed 1998·Granted May 13, 2003·27 cites·56 claims
- 4070US7005502B1Pharmaceutical preparation comprising vWF propeptideBAXTER AG·Filed 1998·Granted Feb 28, 2006·24 cites·5 claims
- 4170US6358534B1Immunotolerant prothrombin complex preparationBAXTER AG·Filed 1998·Granted Mar 19, 2002·32 cites·60 claims
- 4269US6465624B1Purification of von-Willebrand factor by cation exchanger chromatographyBAXTER AG·Filed 1998·Granted Oct 15, 2002·31 cites·22 claims
- 4368US6579723B1Method of recovering highly purified vWF or factor VIII/vWF-complexBAXTER AG·Filed 1998·Granted Jun 17, 2003·34 cites·51 claims
- 4467US6265183B1Direct molecular cloning of foreign genes into poxviruses and methods for the preparation of recombinant proteinsBAXTER AG·Filed 1994·Granted Jul 24, 2001·23 cites·17 claims
- 4566US6548729B1Fibrin spongeBAXTER AG·Filed 1998·Granted Apr 15, 2003·63 cites·42 claims
- 4666US2007161079A1Recombinant cell clones having increased stability and methods of making and using the sameBAXTER AG·Filed 2006·Application pending·0 cites
- 4765US6221363B1Vaccine for the prevention of lyme diseaseBAXTER AG·Filed 1992·Granted Apr 24, 2001·15 cites·18 claims
- 4865US6039945APharmaceutical preparation for treating blood coagulation disordersBAXTER AG·Filed 1998·Granted Mar 21, 2000·13 cites·13 claims
- 4964US6099837APharmaceutical preparation for treating blood coagulation disordersBAXTER AG·Filed 1999·Granted Aug 8, 2000·12 cites·16 claims
- 5061US6165974APharmaceutical preparation for treating blood coagulation disordersBAXTER AG·Filed 1999·Granted Dec 26, 2000·10 cites·19 claims
Showing the top 50 of 73 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when BAXTER AG files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →